Abstract
Ebastine is an H1-receptor antagonist with a relative lack of sedating properties. It is almost completely converted to carebastine, and it is this metabolite which is responsible for the antihistaminic effect. Twelve healthy subjects received a single 20 mg dose of ebastine on day 2 of a multiple oral dosing regimen of either cimetidine (400 mg three times daily and 800 mg in the evening on the day preceding ebastine administration and 400 mg four times daily on the 2 following days) or placebo in a randomised cross-over design. Significant plasma concentrations of ebastine were not detected after either treatment. The AUC of carebastine was not affected by cimetidine coadministration (4049 +/- 985 ng ml-1 h after cimetidine vs 3795 +/- 959 ng ml-1 h after placebo; 95% confidence interval of the difference: -412 to 919). Cimetidine coadministration did not induce any effect of ebastine on blood pressure and heart rate or cause sedation.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Honig P. K., Woosley R. L., Zamani K., Conner D. P., Cantilena L. R., Jr Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther. 1992 Sep;52(3):231–238. doi: 10.1038/clpt.1992.135. [DOI] [PubMed] [Google Scholar]
- Hopes H., Meuret G. H., Ungethüm W., Leopold G., Wiemann H. Placebo controlled comparison of acute effects of ebastine and clemastine on performance and EEG. Eur J Clin Pharmacol. 1992;42(1):55–59. doi: 10.1007/BF00314920. [DOI] [PubMed] [Google Scholar]
- Knodell R. G., Browne D. G., Gwozdz G. P., Brian W. R., Guengerich F. P. Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology. 1991 Dec;101(6):1680–1691. doi: 10.1016/0016-5085(91)90408-d. [DOI] [PubMed] [Google Scholar]
- Kroon C., de Boer A., Hoogkamer J. F., Schoemaker H. C., van der Meer E. J., Edelbroek P. M., Cohen A. F. Detection of drug interactions with single dose acenocoumarol: new screening method? Int J Clin Pharmacol Ther Toxicol. 1990 Aug;28(8):355–360. [PubMed] [Google Scholar]
- Norris H. The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology. 1971 Mar;10(21):181–191. doi: 10.1016/0028-3908(71)90039-6. [DOI] [PubMed] [Google Scholar]
- Powell J. R., Donn K. H. Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications. Am J Med. 1984 Nov 19;77(5B):57–84. [PubMed] [Google Scholar]
- Reynolds J. C. The clinical importance of drug interactions with antiulcer therapy. J Clin Gastroenterol. 1990;12 (Suppl 2):S54–S63. doi: 10.1097/00004836-199000000-00010. [DOI] [PubMed] [Google Scholar]
- Speeg K. V., Jr, Patwardhan R. V., Avant G. R., Mitchell M. C., Schenker S. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology. 1982 Jan;82(1):89–96. [PubMed] [Google Scholar]
- Vincent J., Liminana R., Meredith P. A., Reid J. L. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Br J Clin Pharmacol. 1988 Nov;26(5):497–502. doi: 10.1111/j.1365-2125.1988.tb05288.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vincent J., Sumner D. J., Reid J. L. Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects. Br J Clin Pharmacol. 1988 Nov;26(5):503–508. doi: 10.1111/j.1365-2125.1988.tb05289.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood-Baker R., Holgate S. T. Dose-response relationship of the H1-histamine antagonist, ebastine, against histamine and methacholine-induced bronchoconstriction in patients with asthma. Agents Actions. 1990 Apr;30(1-2):284–286. doi: 10.1007/BF01969062. [DOI] [PubMed] [Google Scholar]